186 related articles for article (PubMed ID: 31063872)
1. Synergy between polymer crystallinity and nanoparticles size for payloads release.
Niyom Y; Phakkeeree T; Flood A; Crespy D
J Colloid Interface Sci; 2019 Aug; 550():139-146. PubMed ID: 31063872
[TBL] [Abstract][Full Text] [Related]
2. PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.
Cavallaro G; Craparo EF; Sardo C; Lamberti G; Barba AA; Dalmoro A
Int J Pharm; 2015 Nov; 495(2):719-27. PubMed ID: 26410757
[TBL] [Abstract][Full Text] [Related]
3. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells.
Aluri R; Jayakannan M
Biomacromolecules; 2017 Jan; 18(1):189-200. PubMed ID: 28064504
[TBL] [Abstract][Full Text] [Related]
4. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles.
Panyam J; Williams D; Dash A; Leslie-Pelecky D; Labhasetwar V
J Pharm Sci; 2004 Jul; 93(7):1804-14. PubMed ID: 15176068
[TBL] [Abstract][Full Text] [Related]
5. Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.
Papadimitriou S; Bikiaris D
J Control Release; 2009 Sep; 138(2):177-84. PubMed ID: 19446585
[TBL] [Abstract][Full Text] [Related]
6. Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behavior.
Karavelidis V; Giliopoulos D; Karavas E; Bikiaris D
Eur J Pharm Sci; 2010 Dec; 41(5):636-43. PubMed ID: 20863892
[TBL] [Abstract][Full Text] [Related]
7. The key role of the drug self-aggregation ability to obtain optimal nanocarriers based on aromatic-aromatic drug-polymer interactions.
Villamizar-Sarmiento MG; Guerrero J; Moreno-Villoslada I; Oyarzun-Ampuero FA
Eur J Pharm Biopharm; 2021 Sep; 166():19-29. PubMed ID: 34052430
[TBL] [Abstract][Full Text] [Related]
8. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets.
Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T
Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747
[TBL] [Abstract][Full Text] [Related]
9. A New Methodology to Create Polymeric Nanocarriers Containing Hydrophilic Low Molecular-Weight Drugs: A Green Strategy Providing a Very High Drug Loading.
Villamizar-Sarmiento MG; Molina-Soto EF; Guerrero J; Shibue T; Nishide H; Moreno-Villoslada I; Oyarzun-Ampuero FA
Mol Pharm; 2019 Jul; 16(7):2892-2901. PubMed ID: 31181908
[TBL] [Abstract][Full Text] [Related]
10. Preparation of biodegradable polymer nanoparticles by miniemulsion technique and their cell interactions.
Musyanovych A; Schmitz-Wienke J; Mailänder V; Walther P; Landfester K
Macromol Biosci; 2008 Feb; 8(2):127-39. PubMed ID: 18213594
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
[TBL] [Abstract][Full Text] [Related]
12. HPMA-based block copolymers promote differential drug delivery kinetics for hydrophobic and amphiphilic molecules.
Tomcin S; Kelsch A; Staff RH; Landfester K; Zentel R; Mailänder V
Acta Biomater; 2016 Apr; 35():12-22. PubMed ID: 26772526
[TBL] [Abstract][Full Text] [Related]
13. Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.
Madsen CG; Skov A; Baldursdottir S; Rades T; Jorgensen L; Medlicott NJ
Eur J Pharm Biopharm; 2015 May; 92():1-7. PubMed ID: 25668778
[TBL] [Abstract][Full Text] [Related]
14. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
15. Development of aqueous ternary nanomatrix films: A novel 'green' strategy for the delivery of poorly soluble drugs.
Kola-Mustapha AT; Armitage D; Abioye AO
Int J Pharm; 2016 Dec; 515(1-2):616-631. PubMed ID: 27825861
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible poly(ethylene succinate) polyester with molecular weight dependent drug release properties.
Abdelghafour MM; Orbán Á; Deák Á; Lamch Ł; Frank É; Nagy R; Ziegenheim S; Sipos P; Farkas E; Bari F; Janovák L
Int J Pharm; 2022 Apr; 618():121653. PubMed ID: 35278604
[TBL] [Abstract][Full Text] [Related]
17. Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices.
Pawar AA; Chen DR; Venkataraman C
Int J Pharm; 2012 Jul; 430(1-2):228-37. PubMed ID: 22469694
[TBL] [Abstract][Full Text] [Related]
18. The interplay of membrane formation and drug release in solution-cast films of polylactide polymers.
Ma D; McHugh AJ
Int J Pharm; 2010 Mar; 388(1-2):1-12. PubMed ID: 20025948
[TBL] [Abstract][Full Text] [Related]
19. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
[TBL] [Abstract][Full Text] [Related]
20. Relationship between polarities of antibiotic and polymer matrix on nanoparticle formulations based on aliphatic polyesters.
Ritsema JAS; Herschberg EMA; Borgos SE; Løvmo C; Schmid R; Te Welscher YM; Storm G; van Nostrum CF
Int J Pharm; 2018 Sep; 548(2):730-739. PubMed ID: 29133206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
